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Abstract: Hepatic allograft-derived lymph nodes were examined in the 
post-transplant period on order to determine the origin of lymphocytes 
and structural elements of the lymph node. Histologic assessment and 
immunohistochemical studies verified that T-cell infiltration of donor 
lymph nodes by recipient-derived lymphocytes occurred early in the post-
transplant period. These T cells bore T-cell activation markers, e.g. TAC 
receptor and HLA-DR antigens. In addition, functional analysis demon-
strated alloreactive T cells in secondary proliferation assays. The pattern 
of alloreactivity in these assays was dependent upon the phenotypic make-
up (and therefore origin) of .the lymphocytes within the lymph node. A 
gradual shift in predominance of donor-derived lymphocytes to recipient-
derived lymphocytes occurred. but even late in the post-transplant course 
the stromal elements and a residium of lymphocytes within the lymph 
nodes continued to bear donor HLA antigens. The possible role of these 
"passenger" lymphocytes in allograft immunity is discussed. 
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The role of "passenger" lymphocytes in the initia-
tion of allograft rejection is not clear; however, 
several lines of evidence suggest that these cells are 
involved in allorecognition. Although these donor 
lymphocytes are generally rapidly eliminated in the 
host (review 1,2), they provide the major stimulus 
of donor-specific sensitization of the transplant 
recipient. Experimental depletion of these cells 
from allografts has been reported to prolong the 
survival of an allograft in animal models (3, 4). 
Under certain circumstances, transplanted 
lymphocytes retain their functional activity to rec-
ognize alloantigens of the recipient, as evidenced 
by graft-versus-host reactions. These observations 
suggest that mutual iniera~:iiEFm: can OCCl.lT hctwep.\l 
immunocompetent donor and recipient lympho-
cytes, and that these interactions may potentiate 
allorecognition (5). 
The most significant immunologic sequelae fol-
lowing transplantation of solid organ allografts is 
rejection of the donor organ by recipient lympho-
cytes. Yet expression of graft-versus-host immuno-
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logic-mediated reactions have been reported fol-
lowing renal (6), hepatic (7), pulmonary (8), splenic 
(9) and pancreaticoduodenal (l0, 11) transplan-
tation. These reactions underscore the immunolo-
gic competency of "passenger" lymphocytes. 
Nevertheless, the generally transient nature of 
these reactions suggests that interactions between 
the recipient immune system and transplanted do-
nor lymphocytes occurs. However, little is known 
regarding the nature of lymphocyte interactions in 
solid allograft transplantation. 
A unique model to study the interactions be-
tween recipient lymphocytes and donor "passen-
ger" lymphocytes is found in human hepatic trans-
plantation. Approximately 15% of liver transplant 
patients undergo allograft hepatectomy with re-
transplantation, generally for unremitting rejec-
tion, but also for primary non-function of the allo-
graft and for technical complications (12, 13). As 
shown in Fig. 1, the donor liver preparation con-
tains numerous hilar lymph nodes which are trans-
planted en bloc into the recipient. These lymph 
nodes therefore retain their normal vascular and 
lymphatic connections to the liver allograft even 
following transplantation. 
In this report, we describe our findings on the 
nature of lymphocytes and their interactions in 
( 
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hepatic hilar lymph nodes and the histological 
changes seen in these lymph nodes following hu-
man hepatic transplantation. 
Materlll In' methods 
Sample/patient profile 
Table I lists the number of days following liver 
transplantation and the indications for allograft 
hepatectomy in the 10 patients studied. In this 
paper, each lymph node (LN) sample is referred to 
by a unique number which identifies the patient 
and the post-transplant day when the hepatectomy 
was performed. For example, LN 1.3, was obtained 
from patient I on the 3rd d post-transplant whereas 
LN6.17 was obtained from patient 6 on the 17th 
d following transplantation. 
Source material 
Liver transplantations were performed by tech-
niques previously developed at our institution (14, 
15). All of the grafts used for hepatic recipients 
were selected without knowledge of their HLA 
types. Post-transplantation, patients were main-
tained on a baseline immunosuppression regimen 
of cyclosporine and steroids. Evidence of allograft 
dysfunction was monitored by histologic, clinical 
and laboratory findings and was supplemented 
with radiographic and ultrasonographic studies 
(16). Treatment of rejection episodes by steroid 
boluses and, at times, the monoclonal anti-human 
T-cell antibody OKT3, has been discussed in detail 
elsewhere (16). The indication for allograft hepa-
tectomy was failure to control allograft dysfunc-
tion along with clinical deterioration. 
Lymph node samples were obtained, in a sterile 
manner, from freshly resected specimens at the time 
of allograft hepatectomy. Hilar lymph nodes were 
dissected close to the confluence of the right and 
left hepatic ducts in order to assure that the lymph 
nodes were of allograft origin. 
Histologic and immunohistochemical studies 
Lymph node samples, sent for histologic examin-
ation using standard hematoxylin and eosin stains, 
were first fixed in neutral buffered formalin and 
sectioned at 4 ~mK Tissues for immunohistochem-
ical staining were embedded in OCT compound, 
sectioned at 4-{) ~m and stained using an indirect 
immunoperoxidase technique. A panel of mono-
clonal antibodies was used that included: OKTll 
(pan-T cell), OKT4 (helper/inducer), OKTS 
(suppressor/cytotoxic), TAC (IL-2 receptor), Bl 
(pan-B cell), DR (HLA-DR) (ORTHO Diagnos-
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tics) as well as type-specifIC anti-Class I MHC 
monoclonal antibodies. 
Lymph nodes from donor/recipient combi-
nations, with selected HLA disparities, were stud-
ied using monoclonal antibodies with specificities 
towards either donor and/or recipient HLA pheno-
types. Monoclonal antibodies with defined anti-
HLA specificities were kind gifts from Drs. John 
Hansen, Genetic Systems, Seattle WA, and Donna 
Kostyu, Duke University, Durham NC (17). A 
double immunoenzymatic method was employed 
for sequential staining using 2 different mono-
clonal antibodies and with 2 different enzymes, as 
previously described (1S). The stained sections 
were analyzed to determine donor or recipient ori-
gin of lymph node structures by differentiating 
between the red and blue color reactions of amino 
ethyl carbazole (AEC) and naphthol AS-MX phos-
phate substrates, respectively. 
Panel cells 
Lymphocytes were obtained by either mechanical 
disruption of donor spleens, obtained during organ 
procurement, or from peripheral blood from hepa-
tic recipients prior to transplantation. These cells 
were isolated by centrifugation over a Ficoll-Hypa-
que gradient (s.g. 1.077) (FicoD-Paque, Pharmacia, 
Piscataway, NJ). Viability was determined with try-
pan blue and cell aliquots were frozen in 20% 
human AB serum and 20% dimethyl sulfoxide, and 
stored in liquid nitrogen. 
Isolation of lymph node lymphocytes 
Single cell suspensions of lymphocytes were ob-
tained from hilar lymph nodes by mechanical dis-
ruption followed by Ficoll-Hypaque density iso-
lation. A portion was sent for determination of 
HLA phenotypes. In addition, an aliquot of the 
lymphocyte suspension was used to determine the 
secondary proliferation proft1e (PLT) towards a 
variety of stimulator cells. 
Primed lymphocyte testing (PLT) 
The PLT activity of lymphocytes obtained from 
extracted lymph nodes was measured in 3-d pro-
liferation assays, as previously described for allore-
active T-cell clones (IS). The relative proliferation 
of 5 x 103 isolated hilar lymph node lymphocytes 
to 5 x 1<t4 irradiated donor stimulator cells, as well 
as irradiated recipient stimulator cells, was deter-
mined following incubation for 72 h. In addition, 
proliferation to recombinant Interleukin-2 (Sandoz 
Pharmaceuticals, Basel) and "spontaneous" pro-
liferation in 10% human AB serum was assessed. 
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During the final 20 h of incubation, each culture 
was pulsed with I JlCi of 3H -thymidine (specific ac-
tivity, 20 mCi/mmole, New England Nuclear Pro-
ducts, Boston, MA). The cultures were harvested 
with a multiple sample harvester (Skatron, Inc., 
Sterling, VA) and uptake was determined by liquid 
scintillation counting (LKB, Gaitherburg, MD). 
HLA phenotyping 
Peripheral blood lymphocytes, donor spleen cells 
and lymph node-derived lymphocytes were typed 
for HLA-A and -B antigens using standard NIH 
microcytotoxicity assays with defined HLA-speci-
fic antisera. Serologic typing for HLA-DR was 
done by prolonged incubation microlymphocyto-
toxicity testing using enriched B-cell preparations 
obtained following carbonyl-iron treatment and 
Ficoll-Hypaque sedimentation after rosetting with 
neuraminidase-treated sheep red cells. 
A portion of the cell suspension obtained from 
allograft lymph nodes was tested in microcytotox-
icity assays to determine the HLA phenotypes of 
these cells. The patterns of reactivity were evalu-
ated in a blinded manner by one of us (M.M.), 
without prior knowledge of donor or recipient 
HLA phenotypes. 
Results 
Histology of lymph nodes 
Morphologically, resting hepatic hilar lymph nodes 
are generally small, measuring 5-10 mm in length. 
However, shortly after transplantation, marked en-
largement of these lymph nodes was seen to occur. 
The changes in the size of the lymph nodes were 
correlated with histologic changes. The earliest his-
Fig. I. Schematic diagram depicting relationship ofhilar hepatic 
lymph nodes to the vascular and biliary anatomoses in liver 
allografts. Note that the location of these lymph nodes (arrow) 
is well on the donor side of the anastomoses. 
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tologic change observed (LN1.3) was hypertrophy 
of the sinusoidal lining and high endothelial ven-
ules (HEV) in the paracortex. Expansion of the 
paracortical area was seen in lymph nodes starting 
1 wk following transplantation, with an increase 
in immunoblasts, some with plasmacytoid features. 
Lymphoid cells could be seen beneath and \\ithin 
the wall of the HEV and sinusoidal lining cells in 
a pattern similar to that seen during early rejection 
patterns seen in most solid organ transplants 
(20-23). Active secondary follicle or germinal cen-
ter formation in the cortex was not a prominent 
feature. 
The most striking changes were observed in 
LN4.9. Grossly, the nodes were enlarged up to 3 
cm in size. Microscopically, the nodal architecture 
was intact. Nodules of small lymphocytes could be 
seen in the cortex and were identified as B-cell 
nodules without active secondary follicle forma-
tion. There was increased cellularity in the T cell-
dependent areas of the lymph nodes, namely the 
interfollicular and paracortical areas (Fig. 2a). Nu-
merous mitoses could be observed with the pres-
ence of immunoblasts and monocytoid cells (Fig. 
2b). The nuclei of cells lining the sinuses and HEV 
were quite prominent and these cells were infil-
trated and undermined by lymphoid cells and lifted 
from the underlying connective tissue (Fig. 2b). 
Again, the appearance was similar to that seen 
during rejection reactions in other tissues. 
Later in the post-transplant period, hepatic hilar 
lymph nodes appeared quiescent with relatively 
normal architecture, as was seen in LN9.693 and 
LNlO.7j5, and their size was the same or smaller 
than normal. Microscopically, these nodes had a 
relative increase in reticuloendothelial cells and a 
relative decrease in lymphoid elements, but retain-
ed the normal segregation of T and B cens (Fig. 
3b,3c). 
Table 1. Indications lor aIograft hepatectomy 
lymph node 
LN 1.3 
LN 2.4 
LN 3.5 
IN 4.9 
LN 5.17 
IN 6.19 
LN 7.59 
IN 8.79 
LN 9.693 
LN 10.755 
kldication for hepatectomy 
passive venous congestion' 
primary graft non-function 
primary graft non-Iunction 
rejectionlhepatic artery thrombosis 
rejection 
rejectiOn/portal vein thrombosis 
rejection 
rejection 
rejection 
rejection 
'Passive venous coogestion ollhe hepatic allograft oa:urred because 01 size 
mismatch and subsequent compression 01 a simultlleously ptaced heart 
allograft 
Immunohistochemical staining of lymph nodes 
T cell-specific monoclonal antibodies were used to 
stain hilar lymph node sections in order to confirm 
that the early hypertrophy was due to an increase 
in T cells. The architectural distribution of T 
lymphoc)1es was similar to that seen in normal 
reactive 1)1TIph nodes. A preponderance ofT4 "hel-
per-inducer" phenotypes was found in these lymph 
nodes. In addition, areas showing T-cell hypercel-
lularity also contained a large number of cells 
which bore TAC receptors, an indicator of T-cell 
activation (Fig. 4). Staining of HLA-DR antigens 
(which is also a marker of T-cell activation) is less 
specific than TAC staining because of the presence 
of HLA-DR antigens on B cells and monocytoid 
cells. Nevertheless, a prominent increase in the 
relative staining of DR-positive cells could be de-
tected in LN4.9, LN5.l7 and LN6.19 (data not 
shown). 
"I~KD . 
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Fig. 2. A) Histologic section ofLN4.9 demonstrating expansion 
of the interfollicuJar cortex and paracortex without formation 
of secondary cortical follicles (40X magnification). B) A higher 
power magnificatioo of LN4.9 showing hypertrophy of the 
HEV endothelium and subendothelial lymphocytic infiltrates 
(arrow head) as weD as mitotic activity oflymphoid cells (arrow) 
found in the paracortical region. 
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The architecture of the lymph nodes remained 
intact throughout the post-transplant period. 
Staining \\-;th Bl revealed that the B cell-dependent 
areas were primarily located in the cortex and re-
tained their normal configuration and did not show 
activated germinal centers. This is in contrast to 
findings previously reported with immunosuppres-
sion consisting of azathioprine and steroids where 
activated germinal centers were a prominent fea-
ture (23). 
HLA phenotypes of hilar lymph node lymphocytes 
Using standard lymphocyte microcytotoxicity as-
says, the HLA reactivity pattern of the lympho-
cytes extracted from hilar lymph nodes was com-
pared to the HLA phenotypes of the donor and 
recipient. As shown in Table 2, as early as 3 d post-
transplant, hepatic hilar lymph nodes apparently 
contained a mixture of donor and recipient 
lymphocytes, as determined by reactivity towards 
HLA-defined antisera. This mixture of donor and 
recipient I)IDphocytes appeared to phenotypically 
shift from predominantly donor origin to predom-
inantly recipient origin during the post-transplant 
period. This was determined by comparison of the 
strength of reaction patterns by complement-me-
diated lymphocytotoxicity assays. Early in the 
post-transplant period, the strongest reactivity was 
towards donor cells, while later the strength of 
reactivity shifted towards recipient patterns (data 
not shown). 
While microlymphocytotoxicity assays were 
used to detect qualitative changes in the reactivity 
pattern of lymph node lymphocytes, these findings 
were verified in several instances by immunohisto-
chemical staining using donor-specific and/or reci-
pient-specific monoclonal anti-HLA antibodies 
(Figs. 3a, 5a, 5b). In this manner a quantitative 
change in the phenotypic makeup of these cells 
could be analyzed. This was particularly evident in 
those lymph nodes which were stained using a 
double immunoenzymatic method with 2 mono-
clonal antibodies, one of donor specificity and the 
other of recipient specificity. 
Two such examples are shown in Fig. 5a and 
5b. In LN 6.19, the donor was HLA typed as 
A25,32,BI8,w60(Bw4,6), while the recipient was 
typed as A2.-;B35,-{Bw6). An HLA-A2-specific 
monoclonal antibody, PS.l, was used to first stain 
recipient-derived cells with a red reaction product, 
which was followed by an HLA-A25-specific 
monoclonal antibody, 1125, to determine struc-
tures which were of donor origin (blue reaction 
product). In this early post-transplant specimen, in 
agreement with cytotoxicity data, both donor and 
recipient lymphocytes can be detected with the 
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stromal elements being of donor origin. Similar 
staining oflymph node samples obtained in the 1st 
month post-transplantation verified a mixture of 
lymph node lymphocytes of both donor and recipi-
ent origin. In the early Iympb node specimens (e.g. 
LN2.4 and LN4.9), the incoming recipient lympho-
cytes could be seen in the peripheral and trabecular 
sinuses. By the 2nd wk:, the larger popUlation of 
recipient lymphocytes was seen in the paracortex 
with lesser numbers in the sinuses. The dual stain-
ing of these early post-transplant lymph nodes con-
firmed that resident and infiltrating lymphocytes 
were of exclusive origins. 
In LN 10.755, the donor was HLA typed as 
A2,-;B51,3S;(Bw6);DR2,5 and the recipient was 
typed as A3,II;B7,w48;(Bw6);DR4,w6. An HLA-
A3-specific monoclonal antibody, GAP-A3, was 
used to first stain recipient-derived cells with a red 
reaction product, which was followed by an HLA-
A2-specific monoclonal antibody, PS.l, to deter-
mine structures which were of donor origin (blue 
reaction product). It is evident that the majority 
of lymphocytes were of recipient origin, while the 
stromal elements, e.g. blood vessels, capsule and 
trabeculae, and residual nests of lymphocytes were 
persistently of donor origin. 
Fig. 3. Immunohistochemical staining of LN 9.693. A) Histologic appearance of this lymph node demonstrates normal architecture 
(not shown). In addition, monodouaJ antibodies with specificity to HLA-A3 demonstrate that the stroma, vascular endothelium 
and scattered foci oflymphoid cells are of donor origin (dark cells) (immunoperoxidase, 40X magnifICation). B) and C) Monoclonal 
anti-T cell and anti-B cell anu"bodies, respectively, were used to demonstrate the normal localization of these lymphocyte subsets 
within the lymph node. 
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Fig. 4. Anti-TAC antibodies were used to identify activated T 
cells within the subcapsular sinus and paracortex in LS4.9. 
Correlation with proliferative reactivity 
Lymphocyte suspensions were tested in PLT assays 
to examine the pattern of proliferation towards 
donor or recipient stimulators. As shown in Table 
3, all lymph node-derived lymphocytes demon-
strated IL-2 responsiveness in PLT assays. 
Lymphocytes, from lymph nodes taken from trans-
plants greater than 1 month old, showed primarily 
reactivity towards donor cells in PLT assays_ On 
the other hand, lymphocytes extracted from lymph 
nodes removed in the early post-transplant period 
showed mixed proliferative responses, varying 
from primarily reactivity towards recipient cells to 
an equal reactivity towards either cell. The func-
tional studies verified the complimentary HLA 
phenotype and PLT alloreactivity of the lympho-
cytes within the lymph node. 
Cells from lymph nodes which showed a miK~ture 
of lymphocytes bearing HLA phenotypes of both 
the donor and recipient (e.g. LN3.5, LN5.17) ap-
Table 2. HLA phenotypes of transplanted allograft lymph node Iympbocytes· 
Patient HLA 
Lymph node A A B B Bw Bw A A 
LN 1.3 3 28 44 35 4 6 1 24 
LN 2.4 1 2 14 w60 6 2 3 
LN 3.5 1 24 35 w55 6 29 31 
LN 4.9 2 - w62 35 6 26 11 
LN 5.17 2 28 27 w60 4 6 2 28 
LN 6.19 2 35 6 25 32 
LN 7.59 2 w33 44 38 4 2 29 
LN 8.79 2 24 8 35 6 2 28 
LN 9.693 1 - w57 4 3 29 
LN 10.755 2 51 35 6 3 11 
"Denotes HLA antigen reactions by microlymphocytotoxicity assays. 
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peared to have equal proliferative reactivity 
towards both donor and recipient cells. In these 
cases, one would expect that the "spontaneous" 
proliferation, i.e. lymph node lymphocytes incu-
bated with 10% human serum only, would be high. 
This would reflect a phenomenon of mutual stim-
ulation of donor - and recipient-derived lympho-
cytes, since both populations would be present in 
culture. Indeed, a high "spontaneous" uptake of 
thymidine was noted in these early post-transplant 
samples. 
DlsClssl •• 
Peripheral lymph nodes (including mesenteric 
lymph nodes) play an important role in the immune 
system and in the development of humoral and 
cell-mediated immunity. Particulate and soluble 
antigens are brought into the lymph node by the 
afferent lymphatics and are optimally processed by 
antigen-processing cells in this environment, with 
subsequent antigenic stimulation of T and B cells. 
A continuously recirculating pool of mature 
lymphocytes influx and exit lymph nodes, presum-
ably in order to optimize chances that an antigen-
specific lymphocyte population, found in the wide 
spectrum of antigen specificities, will encounter a 
specific antigen processed in a lymph node. Lymph 
nodes draining sites of alloantigen immunization 
or allograft transplantation have demonstrated the 
presence of donor-specific alloreactive T cells (24, 
25). 
The model presented here is unique, in that one 
can study the interactions of two immunocompe-
tent lymphocyte populations within an environ-
ment of optimal alloantigen presentation found 
within a lymphoid organ. These interactions ap-
pear to trigger the mutual alloactivation of both 
donor and recipient lymphocytes. Functionally, 
both recipient-specific alloreactive T cells of donor 
DonorHLA Lymph node HLA 
B B Bw Bw A A A B B B Bw Bw 
13 44 4 1 3 28 44 35 - 4 6 
27 35 4 6 2 3 - 27 35w60 4 6 
7 w60 6 1 24 31 35 w60 w55 6 
18 w41 6 2 11 - w62 35 18 6 
44 w57 4 2 28 - 27 w60 44 4 6 
18 w60 4 6 2 25 - 35 4 6 
7 6 NO NO NO NO NO NO NO NO 
44 35 4 6 2 24 28 8 35 - 4 6 
7 44 4 6 1 - w57 4 
7 w48 6 NO NO NO NO NO NO NO NO 
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origin and donor-specific alloreactive T cells of 
recipient origin can be demonstrated, similar to 
that seen in two-way mixed lymphocyte reactions 
(26). The relative intensity of the anti-donor or 
anti-recipient response appears to be directly corre-
lated to the number of recipient or donor lympho-
cytes in the lymph node at the time of testing, as 
determined by immunohistochemical and serologic 
assays. Therefore lymphocytes obtained fairly early 
in the post-transplant course, which phenotypically 
have greater numbers of donor-derived cells, have 
a correspondingly higher anti-recipient response. 
On the other hand, later in the post-transplant 
periods, as continuing replacement of donor 
lymphocytes by recipient-derived lymphocytes oc-
curs, there is a relatively greater anti-donor re-
sponse. 
The fate of donor-derived lymphocytes in hepa-
tic hilar lymph nodes during the post-transplant 
period is not known. A wealth of data has been 
presented by other investigators showing that un-
primed allogeneic hosts rapidly eliminate injected 
Fig. 5. A) Two-color immunohistochemical staining of LN6.l9, 
using monoclonal anti-donor and recipient HLA antibodies, 
show that the lymphoid cells contain a mixture of donor (anti-
HLA A2S, blue) and recipient (anti-HLA A2, red) lymphocytes, 
while the stromal elements are of donor origin. B) Similarly, in 
LNlO.755, while the majority of lymphoid cells are of recipient 
origin (anti-HLA A2, red), the stromal elements and isolated 
nests oflympboid cells are of donor origin (anti-HLA A3, blue). 
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donor lymphocytes, termed "natural cytotoxicity" 
(1). We have been able to demonstrate a low degree 
of donor-specific Iymphocytotoxicity in such 
lymph nodes (data not shown here), but it is not 
clear whether this is the primary mode of allogeneic 
lymphocyte elimination. It is likely that the physi-
ologic process of exodus of lymphocytes from a 
lymph node into the peripheral circulation con-
tinues within these nodes. Transplanted lymph 
nodes in a rodent model have shown rapid reestab-
lishment of efferent lymphatic channels with func-
tional lymphatic drainage (27-29). 
Influx of recipient-derived lymphocytes into al-
logeneic donor lymph nodes may take place by 
two mechanisms, one by transit through the high 
endothelial cells lining the post-capillary venules of 
the lymph node (30), or via afferent lymphatic 
channels draining the liver allograft. It is likely 
that both mechanisms are involved. Histologically, 
there is massive hypertrophy of T cell-dependent 
areas and these T cells bear activation markers . 
The B-cell areas within the lymph nodes appear to 
be less affected following transplantation. These 
samples were taken from patients who had been 
on cyclosporine, and the primary mode of action 
of cyclosporine is modulation of T-cell activation 
(31). It is possible that while T-celI activation con-
tinues to occur in allograft lymph nodes, the release 
of lymphokines (such as B-cell growth factor) is 
modulated and subsequent B-cell responses are 
diminished. In earlier studies of hepatic-derived 
lymph nodes taken from patients on azathioprine/ 
steroid therapy, it was noted that substantial hy-
pertrophy occurred in B cell-dependent areas (23). 
Several investigators have suggested that specific 
homing mechanisms or recirculating lymphocytes 
into peripheral lymph nodes is MHC-restricted 
Table 3. Proliferative reactivities of transplcw1ted allograft lymph node lympho-
cytes 
3ti-lhymidine uptake (CPM), 
10% AB Recombinalt Donor Recipient 
Lymph node (spontaneous) interteukin-2 stimulatedt stimulatedt 
LN 1.3 1.444 6.232 4,293 9.547 
LN 2.4 4.242 7.083 1.563 12.506 
LN 3.5 11,008 53,769 13,521 12.258 
LN 4.9 2.302 25.130 13,927 4,711 
LN 5.17 6,723 16.801 18.070 19.375 
LN 6.19 10.066 17.180 26.772 8,581 
LN 7.59 8n 17,347 26,336 3,202 
LN 8.79 1,612 35,6911 51,620 3,787 
LN 9.693 1.002 12,556 14,434 2.090 
LN 10.755 1,n3 21,944 8.805 1,266 
'Uptake or 'H-thymidlne was determined iI 3 d proliferation assays. 
tlrradiated lymphocytes were used as the source lor stimulating cells in PLT 
assays. 
---------------------------------~+-I---K-------------------
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(32-34). Rolstad and Ford (2) have forwarded the 
contrary view that such migration is not MHC-
restricted. Certainly the data presented here sup-
ports the latter contention, although the infil-
tration of allospecific recipient lymphocytes may 
also be modulated by other factors, e.g. soluble 
chemotactic factors, secreted by alloactivated 
lymph0C)1es. 
The presence of persistently acquired immuno-
globulin of donor allotype in some liver transplant 
recipients has suggested that donor lymphocytes 
are present in long-term allografts (35). Indeed, we 
have been able to detect residual nests of donor 
lymphocytes within lymph nodes from long-term 
functioning allografts. However, it cannot be deter-
mined at this time whether it is this residuum of 
lymphocytes or the plasma cells normally found 
within the liver parenchyma that is responsible for 
continued antibody secretion following transplan-
tation. Finally, in agreement with studies by Porter 
(23), we found that structural and stromal elements 
continue to bear donor phenotypes. 
Outside of the obvious interest of using this 
model to study lymph node physiology and immu-
nology, one can also begin to speculate as to the 
role of "passenger" lymphocytes in the develop-
ment of allograft immunity. Lacy et a1. (4) first 
demonstrated that pretreatment of islet allografts, 
in order to eliminate "passenger" lymphoid cel1s, 
could prolong the survival of these allografts in 
rodents. Prop et a1. (3) demonstrated that removal 
of bronchus-associated lymphoid tissues (BALT) 
resulted in diminished lung rejection in rodents. 
The reason(s) for this phenomenon is not clear, but 
certainly lymphocytes. bearHLAantigensand are 
potent stimulators of alloactivation. One might ex-
peet that their removal would diminish the degree 
of antigenicity of the allograft. The mechanism(s) 
involved in the infiltration and alloactivation of T 
cells into lymph nodes may be the same as that 
seen in allografts. Preliminary data from immuno-
genetic analysis of cloned T cells from these reject-
ed human liver allografts and hilar lymph nodes 
has shown similar patterns of reactivity to HLA-
defined antigens. 
This phenomenon does not appear to be unique 
to hepatic allografts only; in two instances where 
hilar lymph nodes were examined from human lung 
allografts, there appeared to be variable pheno-
typic expressions of donor- and recipient-derived 
lymphocytes. In addition, a high degree of "spon-
taneous" proliferation was seen in the lymph node-
derived lymphocyte suspension from a lung allo-
graft removed 10 d post-transplant. We have pre-
viously shown that these lung allografts undergo a 
transition period whereby bronchoalveolar macro-
phages and lymphocytes (obtained by bronchoal-
Origin of al10graft lymph node structures 
veolar lavage) appear to shift from donor to recipi-
ent origin (36, 37). Interestingly, a similar phenom-
enon of high "spontaneous" proliferation was 
noted in bronchoalveolar cells phenotypically 
showing mixtures of donor and recipient cells. As 
with hepatic hilar lymph nodes, lymphocytes iso-
lated from bronchoalvolar lavages have demon-
strated donor-specific secondary proliferation (5, 
36). 
Since the majority of acute cell-mediated rejec-
tion episodes occur within the first few months 
following transplantation, and because it is during 
this period that interactions between donor and 
recipient lymphocytes occur, it is possible that these 
events may be related. Further study of role of 
"passenger" lymphocytes in the development of 
allograft immunity may elucidate the mechanism(s) 
and possible therapeutic interventions of allograft 
rejection. 
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